Dr Joshua Nass, of the Michigan Institute for Neurological Disorders, discussed the 10 most common signs of ailing health ...

All eyes will be on reaction to the Q1 earnings from Infosys, Dr. Reddy’s Labs and Tata Consumer Products, with ...

Not all the news was good. D.R. Horton beat earnings soundly, but its $3.36 per share profit still declined 18% versus Q3 ...

Infosys, Coforge, Dr Reddy's Lab, Bajaj Housing Finance, Bikaji Foods, Tata Consumer Products among 58 companies to release ...

Investing.com - Jefferies has raised the price target on Dr. Reddy’s Laboratories Ltd. (DRRD:IN) (NYSE:RDY) to INR1,100.00 from INR1,010.00 while maintaining an Underperform rating on the stock. The p ...

Dr Reddy's Laboratories reported a 1% rise in net profit for the June quarter, with revenues increasing from Rs 7,673 crore to Rs 8,545 crore. Despite facing pricing pressures in the US generic market ...